Alexander L. Weis
Chief Executive Officer at ONCOVISTA INNOVATIVE THERAPIES, INC.
Alexander L. Weis active positions
Companies | Position | Start | End |
---|---|---|---|
ONCOVISTA INNOVATIVE THERAPIES, INC. | Comptroller/Controller/Auditor | 15/08/2007 | - |
Chief Executive Officer | 15/08/2007 | - | |
Director of Finance/CFO | 31/07/2009 | - | |
President | 15/08/2007 | - | |
Chairman | 15/08/2007 | - | |
Corporate Secretary | 15/08/2007 | - | |
Alere Diagnostics GmbH
Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Chief Executive Officer | 31/01/2009 | - |
Chairman | 31/01/2009 | - | |
OncoVista-Sub | Chief Executive Officer | - | - |
Chairman | 31/08/2004 | - | |
Founder | 31/08/2004 | - | |
President | 31/08/2004 | - |
Career history of Alexander L. Weis
Former positions of Alexander L. Weis
Companies | Position | Start | End |
---|---|---|---|
Aviation Upgrade Technologies, Inc. | President | - | 13/01/2008 |
OncoVista, Inc.
OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | President | - | 13/01/2008 |
Lipitek International, Inc. | Founder | 31/12/1988 | 31/08/2004 |
President | 31/12/1988 | 31/08/2004 | |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Tech/Sci/R&D Officer | 31/12/1993 | 31/12/1997 |
Founder | 31/12/1993 | 31/12/1997 | |
Sterling Drug, Inc. | Corporate Officer/Principal | - | - |
EASTMAN KODAK COMPANY | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Alexander L. Weis
N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry | Doctorate Degree |
Statistics
International
United States | 9 |
Germany | 2 |
Israel | 2 |
Operational
President | 5 |
Chief Executive Officer | 3 |
Chairman | 3 |
Sectoral
Health Technology | 4 |
Producer Manufacturing | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
EASTMAN KODAK COMPANY | Producer Manufacturing |
ONCOVISTA INNOVATIVE THERAPIES, INC. | Health Technology |
Private companies | 7 |
---|---|
Alere Diagnostics GmbH
Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Health Technology |
Aviation Upgrade Technologies, Inc. | Producer Manufacturing |
OncoVista, Inc.
OncoVista, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoVista, Inc. develops cancer treatment technology. The firm provides drug discovery technologies, clinical development and registration strategies solutions. The company was founded in 2004 and is located in San Antonio, TX. | Electronic Technology |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Sterling Drug, Inc. | Consumer Non-Durables |
Lipitek International, Inc. | |
OncoVista-Sub |
- Stock Market
- Insiders
- Alexander L. Weis
- Experience